Overexpression of Par-4 Sensitizes TRAIL-Induced Apoptosis Via Inactivation of NF-kB and Akt Signaling Pathways in Renal Cancer Cells
- Author(s)
- Tae-Jin Lee; Ji-Hoon Jang; Hyo-Jeong Noh; Eun-Jung Park; Kyeong-Sook Choi; Taeg-Kyu Kwon
- Keimyung Author(s)
- Kwon, Taeg Kyu
- Department
- Dept. of Immunology (면역학)
- Journal Title
- Journal of Cellular Biochemistry
- Issued Date
- 2010
- Volume
- 109
- Issue
- 5
- Keyword
- PAR-4; TRAIL; DR5; APOPTOSIS; NF-KB; AKT
- Abstract
- The prostate-apoptosis-response-gene-4 (Par-4) is up-regulated in prostate cells undergoing programmed cell death. Furthermore, Par-4 protein has been shown to function as an effector of cell death in response to various apoptotic stimuli that trigger mitochondria and membrane receptor-mediated cell death pathways. In this study, we investigated how Par-4 modulates TRAIL-mediated apoptosis in TRAIL-resistant Caki cells. Par-4 overexpressing cells were strikingly sensitive to apoptosis induced by TRAIL compared with control cells. Par-4 overexpressing Caki cells treated with TRAIL showed an increased activation of the initiator caspase-8 and the effector caspase-3, together with an enforced cleavage of XIAP and c-FLIP. TRAIL-induced reduction of XIAP and c-FLIP protein levels in Par-4 overexpressing cells was prevented by z-VAD pretreatment. In addition, the surface DR5 protein level was increased in TRAIL-treated Par-4 overexpressing cells. Interestingly, even though a deletion of leucine zipper domain in Par-4 recovered Bcl-2 level to basal level induced by wild type Par-4, it partly decreased sensitivity to TRAIL in Caki cells. In addition, exposure of Caki/Par-4 cells to TRAIL led to reduction of phosphorylated Akt levels, but deletion of leucine zipper domain of Par-4 did not affect these phosphorylated Akt levels. In conclusion, we here provide evidence that ectopic expression of Par-4 sensitizes Caki cells to TRAIL via modulation of multiple targets, including DR5, Bcl-2, Akt, and NF-κB.
- 공개 및 라이선스
-
- 파일 목록
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.